Treatment of extra - abdominal desmoid tumors with chemotherapy

Cancers

Volumn 3, Issue 3, 2011, Pages 3394-3404

  Montgomery, Corey ^a   Emory, Cynthia ^b   Adams, Sheila ^c   Cohen, Jonathan ^c   Pitcher, John David ^c   Potter, Benjamin Kyle ^d   Temple, H Thomas ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Desmoid tumors; Fibromatosis; Methotrexate; Vinblastine; Vinorelbine

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; FOLINIC ACID; METHOTREXATE; NAVELBINE; VINBLASTINE;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHILD; CHRONIC DIARRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; FIBROMATOSIS; FOLLOW UP; HUMAN; MALE; NAUSEA; NEUROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS PNEUMONIA; RECURRENT CANCER; SCHOOL CHILD; STOMATITIS; TREATMENT DURATION; TUMOR VOLUME;

EID: 80053196605     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3033394     Document Type: Article

References (41)

1. Weiss, S.W.; Goldblum, J.R. Fibromatosis, in Enzinger and Weiss. In Soft-Tissue Tissue Tumors; 4th ed.; Mosby: Philadelphia, PA, USA, 2001.
2. Micke, O.; Seegenschmiedt, M.H.; German Cooperative Group on Radiotherapy for Benign Diseases. Radiation therapy for aggressive fibromatosis (desmoid tumors): Results of a national patterns of care study. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61, 882-891.
3. Hosalkar, H.S.; Fox, E.J.; Delaney, T.; Torbet, J.T.; Ogilive, C.M.; Lackman, R.D. Desmoid tumors and current status of management. Orthop. Clin. North Am. 2006, 37, 53-63.
4. Pignatti, G.; Barbanti-Bròdano, G.; Ferrari, D.; Gherlinzoni, F.; Bertoni, F.; Bacchini, P.; Barbieri, E.; Giunti, A.; Campanacci, M. Extraabdominal desmoid tumor. A study of 83 cases. Clin. Orthop. Relat. Res. 2000, 375, 207-213.
5. Lewis, J.J.; Boland, P.J.; Leung, D.H.; Woodruff, J.M.; Brennan, M.F. The enigma of desmoid tumors. Ann. Surg. 1999, 229, 866-872.
6. Hosalkar, H.S.; Torbert, J.T.; Fox, E.J.; Delaney, T.F.; Aboulafia, A.J.; Lackman, R.D. Musculoskeletal desmoid tumors. J. Am. Acad. Orthop. Surg. 2008, 16, 188-198.
7. Alman, B.A.; Li, C.; Pajerski, M.E.; Diaz-Cano, S.; Wolfe, H.J. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis (desmoid tumors). Am. J. Pathol. 1997, 151, 329-334.
8. Giarola, M.; Wells, D.; Mondini, P.; Pilotti, S.; Sala, P.; Azzarelli, A.; Bertario, L.; Pierotti, M.A.; Delhanty, J.D.; Radice, P. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumors. Br. J. Cancer 1998, 78, 582-587.
9. Brandal, P.; Micci, F.; Bjerkehagen, B.; Eknaes, M.; Larramendy, M.; Lothe, R.A.; Knuutila, S.; Heim, S. Molecular cytogenetic characterization of desmoid tumors. Cancer Genet. Cytogenet. 2003, 146, 1-7.
10. Shido, Y.; Nishida, Y.; Nakashima, H.; Katagiri, H.; Sugiura, H.; Yamada, Y.; Ishiguro, N. Surgical treatment for local control of extremity and trunk desmoid tumors. Arch. Orthop. Trauma Surg. 2009, 129, 929-933.
11. Pritchard, D.J.; Nascimento, A.G.; Petersen, I.A. Local control of extra-abdominal desmoid tumors. J. Bone. Joint. Surg. Am. 1996, 78, 848-854.
12. Guadagnolo, B.A.; Zagars, G.K.; Ballo, M.T. Long-term outcomes for desmoid tumors treated with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 71, 441-447.
13. Rüdiger, H.A.; Ngan, S.Y.; Ng, M.; Powell, G.J.; Choong, P.F. Radiation therapy in the treatment of desmoid tumours reduces surgical indications. Eur. J. Surg. Oncol. 2010, 36, 84-88.
14. Nuyttens, J.J.; Rust, P.F.; Thomas, C.R., Jr.; Turrisi, A.T., 3rd. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer 2000, 88, 1517-1523
15. Baliski, C.R.; Temple, W.J.; Arthur, K.; Schachar, N.S. Desmoid tumors: A novel approach for local control. J. Surg. Oncol. 2002, 80, 96-99.
16. Janinis, J.; Patriki, M.; Vini, L.; Aravantios, G.; Whelan, J.S. The pharmacological treatment of aggressive fibromatosis: A systematic review. Ann. Oncol. 2003, 14, 181-190.
17. Tsukada, K.; Church, J.M.; Jagelman, D.G.; Fazio, V.W.; McGannon, E.; George, C.R.; Schroeder, T.; Lavery, I.; Oakley, J. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis. Colon. Rectum. 1992, 35, 29-33.
18. Poon, R.; Smits, R.; Li, C.; Jagmohan-Changur, S.; Kong, M.; Cheon, S.; Yu, C.; Fodde, R.; Alman, B.A. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 2001, 20, 451-460.
19. Waddell, W.R.; Kirsch, W.M. Testolactone, sulindac, warfarin, and vitamin K for unresectable desmoid tumors. Am. J. Surg. 1991, 161, 416-421.
20. Hansmann, A.; Adolph, C.; Vogel, T.; Unger, A.; Moeslein, G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004, 100, 612-620.
21. Ohashi, T.; Shigematsu, N.; Kameyama, K.; Kubo, A. Tamoxifen for recurrent desmoid tumor of the chest wall. Int. J. Clin. Oncol. 2006, 11, 150-152.
22. Weiss, A.J.; Lackman, R.D. Low-dose chemotherapy of desmoid tumors. Cancer 1989 15, 64, 1192-1194.
23. Weiss, A.J.; Lackman, R.D. Therapy of desmoid tumors and related neoplasms. Compr. Ther. 1991, 17, 32-34.
24. Azzarelli, A.; Gronchi, A.; Bertulli, R.; Terso, J.; Baratti, D.; Pennacchioli, E.; Dileo, P.; Raponi, A.; Ferrari, A.; Pilotti, S.; Casali, P. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001, 92, 1259-1264.
25. Skapek S.X.; Hawk, B.J.; Hoffer, F.A.; Dahl, G.V.; Granowetter, L.; Gebhardt, M.; Ferguson, W.S.; Grier, H.E. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J. Clin. Oncol. 1998, 16, 3021-3027.
26. Skapek, S.X.; Ferguson, W.S.; Granowetter, L.; Devidas, M.; Perez-Atayde, A.R.; Dehner, L.P.; Hoffer, F.A.; Speights, R.; Gebhardt, M.C.; Dahl, G.V.; et al. Vinblastine and methotrexate for desmoid fibromatosis in children: Results of a Pediatric Oncology Group Phase II Trial. J. Clin. Oncol. 2007, 25, 501-506.
27. Lackner, H.; Urban, C.; Benesch, M.; Raith, J.; Moser, A.; Sovinz, P.; Schwinger, W.; Dornbusch, H.J.; Triebl-Roth, K. Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. J. Pediatr. Hematol. Oncol. 2004, 26, 518-522.
28. Reich, S.; Overberg-Scmidt, U.S.; Buhrer, C.; Henze, G. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. J. Clin. Oncol. 1999, 17, 1086.
29. Weiss, A.J.; Horowitz, S.; Lackman, R.D. Therapy of desmoid tumors and fibromatosis using vinorelbine. Am. J. Clin. Oncol. 1999, 22, 193-195.
30. Constantinidou, A.; Jones, R.L.; Scurr, M.; Al-Muderis, O.; Judson, I. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur. J. Cancer 2009, 45, 2928-2929.
31. Portiz, L.S.; Blackstein, M.; Berk, T.; Gallinger, S.; McLeod, R.S.; Cohen, Z. Extended follow-up of patient's treatment with cytotoxic chemotherapy for intra-abdominal desmoid tumors. Dis. Colon. Rectum. 2001, 44, 1268-1273.
32. Schnitzler, M.; Cohen, Z.; Blackstein, M.; Berk, T.; Gallinger, S.; Madlensky, L.; McLeod, R. Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis. Colon. Rectum. 1997, 40, 798-801.
33. Patel, S.R.; Evans, H.L.; Benjamin, R.S. Combination chemotherapy in adult desmoids tumors. Cancer 1993, 72, 3244-3247.
34. Okuno, S.H.; Edmonson, J.H. Combination chemotherapy for desmoid tumors. Cancer 2003, 97, 1134-1135.
35. Raney, B.; Evans, A.; Granowetter, L.; Schnaufer, L.; Uri, A.; Littman, P. Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics 1987, 79, 394-398.
36. Klaase, J.M.; Kroon, B.B.; Benckhuijsen, C.; van Geel, A.N.; Albus-Lutter, C.E.; Wieberdink, J. Results of regional isolation perfusion with cytostatics in patients with soft tissue tumor of the extremities. Cancer 1989, 64, 616-621.
37. Heinrich, M.C.; McArthur, G.A.; Demetri, G.D.; Joensuu, H.; Bono, P.; Herrmann, R.; Hirte, H.; Cresta, S.; Koslin, D.B.; Corless, C.L.; et al. Clinical and molecular studies of the effect of imantinib on advanced aggressive fibromatosis (demoid tumor). J. Clin. Oncol. 2005, 24, 1195-1203.
38. Skubitz, K.M.; Manivel, J.C.; Clohisy, D.R.; Frolich, J.W. Response of imatinib-resistant extrabdominal aggressive fibromatosis to sunitinib: Case report and review of literature on response to tyrosine-kinase inhibitors. Cancer Chemother. Pharmacol. 2009, 64, 635-640.
39. Mace, J.; Biermann, J.S.; Dondak, V.; McGinn, C.; Hayes, C.; Thomas, D.; Baker, L. Response of extraabdominal desmoids tumors to therapy with imanitib mesylate. Cancer 2002, 95, 2373-2379.
40. Stengele, G.; Metze, D.; Dorflinger, B.; Luger, T.A.; Böhm, M. Treatment of extra-abdominal aggressive desmoids tumors with pegylated interferon. J. Am. Acad. Deramtol. 2008, 59, S7-S9.
41. Fernberg, J.O.; Brosjo, O.; Larsson, O.; Soderlund, V.; Strander, H. Interferon-induced remission in aggressive fibromatosis of the lower extremity. Acta Oncol. 1999, 38, 971-972.